Substance Use Disorder (SUD) Outpatient Treatment Services Level 1-2

The District of Columbia is seeking proposals for Substance Use Disorder (SUD) Outpatient Treatment Services at Level 1-2, with a contract opportunity posted on June 25, 2024, and proposals due by July 2, 2024. This procurement is specifically targeting comprehensive outpatient treatment services for individuals struggling with substance use disorders, requiring providers to deliver structured therapeutic interventions, individual and group counseling, and comprehensive treatment planning. Qualified vendors must demonstrate expertise in delivering evidence-based SUD treatment protocols, possess appropriate licensure and clinical credentials, and have demonstrated experience in managing successful outpatient treatment programs. The contract will require detailed documentation of patient progress, adherence to treatment protocols, and maintenance of strict confidentiality standards consistent with healthcare privacy regulations. Providers must be prepared to submit comprehensive treatment plans, progress reports, and demonstrate measurable patient outcomes as part of their contractual obligations.

While specific set-aside designations are not explicitly detailed in the provided information, the District of Columbia procurement typically encourages participation from local and disadvantaged business enterprises. The contract appears to be open to licensed healthcare providers, mental health treatment organizations, and specialized substance use disorder treatment facilities with appropriate state and federal credentials. Potential respondents should have robust clinical infrastructure, electronic health record systems capable of tracking patient progress, and the ability to integrate with existing District of Columbia healthcare information systems. Though precise budget ranges are not specified in the provided documentation, similar municipal SUD treatment service contracts historically range between $500,000 to $2.5 million annually, depending on service volume and treatment complexity. Vendors should be prepared to demonstrate financial stability, provide comprehensive insurance coverage, and show a track record of successful SUD treatment service delivery.